Mode
Text Size
Log in / Sign up
N/A Completed N=58 Prevention

Intensive Aerobic and Resistance Exercise Program (IAREP)

Type 2 Diabetes Mellitus · Mild Cognitive Impairment · Non-insulin-dependent Diabetes Mellitus · Cognitive Dysfunction
Source: ClinicalTrials.gov NCT06401733 ↗
Enrolled (actual)
58
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcomePrimary: Change in Cognitive Function Based on Risk Stratification Score (RSS) — -0.2; -0.1; -0.8; 0.0 score on a scale

Summary

A 12-week Intensive Aerobic and Resistance Exercise Program (IAREP) intervention was implemented on high-risk and low-risk subjects with cognitive impairment in type 2 Diabetes Mellitus. The study aims to evaluate the effectiveness of IAREP on cognition, metabolic and inflammatory health, physical function, vascular health, and health practice behaviour in the Type 2 Diabetes Mellitus population (T2DM).

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Cognitive Function Based on Risk Stratification Score (RSS)
-0.2; -0.1; -0.8; 0.0
PRIMARY
Number of Participants With Change in Cognitive Function (Cognitive Impairment) Based on Vascular Dementia Battery (VDB)
10; 16; 8; 14
PRIMARY
Change in Cognitive Function Based on the Montreal Cognitive Assessment (MoCA)
25.0; 24.5; 25.0; 24.0
SECONDARY
Change in Metabolic Health
SECONDARY
Change in Inflammatory Condition
SECONDARY
Change in Short Physical Performance Battery (SPPB)
SECONDARY
Change in Sarcopenia Risk
SECONDARY
Change in Blood Pressure
SECONDARY
Change in Physical Activity: International Physical Activity Questionnaire - Short Form
SECONDARY
Change in Self-care of Diabetes Index (SCODI)
SECONDARY
Change in Self-related and Health Practice (SRAHP)

Eligibility Criteria

Inclusion Criteria

  • Aged 40 to 85
  • Living in the community
  • Diagnosed with type 2 diabetes mellitus (T2DM)
  • Literate in English or Mandarin
  • Activities of daily living (ADL)-independent
  • Obtain at least a score of 5 in short physical performance battery (SPPB) test

Exclusion criteria

  • Severe cognitive (e.g., dementia) or psychiatric disorders (e.g., schizophrenia or severe depression)
  • Severe hearing or vision impairments
  • Terminally ill medical conditions (e.g., end stage cancer), severe cardiovascular, respiratory (e.g., respiratory failure), or orthopedic conditions (e.g., freeze shoulder)
  • Absolute contraindications to aerobic exercise and resistance training programs (e.g., recent myocardial infarction or electrocardiography changes, complete heart block, acute congestive heart failure, unstable angina, uncontrolled hypertension)
  • Pregnant or breastfeeding women
  • Uncomfortable with video-recording of intervention sessions
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06401733). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search